Operational Plasticity Enables Hsp104 to Disaggregate Diverse Amyloid and Nonamyloid Clients  by DeSantis, Morgan E. et al.
Operational Plasticity Enables
Hsp104 to Disaggregate Diverse
Amyloid and Nonamyloid Clients
Morgan E. DeSantis,1,2 Eunice H. Leung,1 Elizabeth A. Sweeny,1,2 Meredith E. Jackrel,1 Mimi Cushman-Nick,1,3
Alexandra Neuhaus-Follini,1,3 Shilpa Vashist,1 Matthew A. Sochor,1,2 M. Noelle Knight,1,2 and James Shorter1,2,3,*
1Department of Biochemistry and Biophysics
2Biochemistry and Molecular Biophysics Graduate Group
3Neuroscience Graduate Group
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
*Correspondence: jshorter@mail.med.upenn.edu
http://dx.doi.org/10.1016/j.cell.2012.09.038SUMMARY
It is not understood how Hsp104, a hexameric AAA+
ATPase from yeast, disaggregates diverse struc-
tures, including stress-induced aggregates, prions,
and a-synuclein conformers connected to Parkinson
disease. Here, we establish that Hsp104 hexamers
adapt different mechanisms of intersubunit collabo-
ration to disaggregate stress-induced aggregates
versus amyloid. To resolve disordered aggregates,
Hsp104 subunits collaborate noncooperatively via
probabilistic substrate binding and ATP hydrolysis.
To disaggregate amyloid, several subunits coopera-
tively engage substrate and hydrolyze ATP. Impor-
tantly, Hsp104 variants with impaired intersubunit
communication dissolve disordered aggregates,
but not amyloid. Unexpectedly, prokaryotic ClpB
subunits collaborate differently than Hsp104 and
couple probabilistic substrate binding to cooperative
ATP hydrolysis, which enhances disordered aggre-
gate dissolution but sensitizes ClpB to inhibition
and diminishes amyloid disaggregation. Finally, we
establish that Hsp104 hexamers deploy more sub-
units to disaggregate Sup35 prion strains with more
stable ‘‘cross-b’’ cores. Thus, operational plasticity
enables Hsp104 to robustly dissolve amyloid and
nonamyloid clients, which impose distinct mechan-
ical demands.INTRODUCTION
Several fatal neurodegenerative disorders, including Parkinson
disease (PD), are connected with the misfolding of specific
proteins into soluble toxic oligomers and stable cross-b fibers,
termed amyloid (Cushman et al., 2010). Amyloidogenesis is
also a severe problem in recombinant protein purification from
diverse systems ranging from bacteria to animal cells. Here,778 Cell 151, 778–793, November 9, 2012 ª2012 Elsevier Inc.overexpressed proteins form inclusions and adopt the amyloid
form (Wang et al., 2008). Thus, amyloid frustrates basic structural
and functional studies and limits production of valuable thera-
peutic proteins in the pharmaceutical sector. The dearth of
solutions to these problems reflects a profound gap in our
understanding of how cells safely reverse amyloid formation.
Amyloid disaggregation is coupled to degradation in animal
cell extracts, but the identity of the disaggregase is unknown (Co-
hen et al., 2006). Moreover, Hsp110, Hsp70, and Hsp40, the
metazoan protein-disaggregase system, cannot rapidly dis-
aggregate amyloid (Shorter, 2011). Perplexingly, animals lack
Hsp104 orthologs, which are found in bacteria, fungi, protozoa,
chromista, and plants. Hsp104 is a hexameric, ring-shaped
translocase with two AAA+ nucleotide-binding domains (NBDs)
per subunit that couple ATP hydrolysis to protein disaggregation
(Vashist et al., 2010). In yeast, Hsp104 promotes survival of
protein-folding stress by collaborating with Hsp70 and Hsp40
to renature the entire aggregated proteome (Parsell et al., 1994;
Vashist et al., 2010). Thioflavin-T (ThT) fluorescence, Congo red
binding, sedimentation, electron microscopy, and SDS resis-
tance have been used to establish that Hsp104 rapidly remodels
various amyloid forms, including Sup35 andUre2 prions. Hsp104
also rapidly eliminates preamyloid oligomers that accumulate
prior to fibers (Shorter and Lindquist, 2004, 2006). Thus,
Hsp104 enables yeast to harness infectious amyloids, termed
prions, for beneficial purposes (Halfmann et al., 2012; but see
also Wickner et al., 2011). How Hsp104 disaggregates such a
diverse repertoire of structures, ranging from stable amyloid to
less stable disordered aggregates (Knowles et al., 2007; Wang
et al., 2010), is not understood. This immense substrate diversity
imposes extreme mechanical demands on Hsp104.
The loss of Hsp104 from metazoa is baffling. Transgenic
mice expressing Hsp104 are normal, and Hsp104 increases
stress tolerance of animal cells (Dandoy-Dron et al., 2006). More-
over, Hsp104 directly remodels PD-associated oligomers and
amyloids formed by a-synuclein (a-syn) and rescues rodent
models of PD and Huntington disease (HD) (Lo Bianco et al.,
2008; Vacher et al., 2005). Thus, Hsp104 could be developed
as a therapeutic disaggregase for neurodegenerative disorders
(Vashist et al., 2010).
Ideally, to optimize therapy and minimize side effects, Hsp104
would be engineered and potentiated to dissolve specific aggre-
gates central to the disease in question (Vashist et al., 2010).
Indeed, Hsp104’s disaggregase activity could be enhanced
and tailored for any protein. Thus, substrate-optimized Hsp104
variants could increase protein solubility and enable facile
purification of recalcitrant proteins in diverse settings. However,
limited structural andmechanistic understanding of Hsp104 hex-
amers frustrates such endeavors. It is not understood how
individual subunits of the Hsp104 hexamer coordinate sub-
strate translocation and ATP hydrolysis to solubilize unrelated
proteins trapped in energetically and structurally distinct aggre-
gates (Doyle et al., 2007b; Lee et al., 2010; Tessarz et al., 2008;
Wendler et al., 2007, 2009).
Do Hsp104 hexamers use the same mechanism to disaggre-
gate amyloid and nonamyloid clients? Specific mutations in
Hsp104 differentially affect its activity against prions and
disordered aggregates, as does ATPgS, a slowly hydrolyzable
ATP analog, suggesting a mechanistic dichotomy or plasticity
(Doyle et al., 2007b; Kurahashi and Nakamura, 2007). This
dichotomy might reflect an ability of Hsp104 subunits to collab-
orate differently to promote dissolution of diverse aggregated
structures.
How individual subunits collaborate to promote substrate
remodeling is a key question not only for Hsp104 but for all
NTP-fueled, hexameric ring-translocases. Several different in-
tersubunit collaboration models have been proposed, including
(1) probabilistic models in which individual subunits function
noncooperatively and independently (Martin et al., 2005); (2)
models of subglobal cooperativity where a subset of subunits
cooperate (Moreau et al., 2007); and (3) models of global coop-
erativity in which all subunits cooperate in sequence or in concert
(Lyubimov et al., 2011). Typically, these models focus on coordi-
nation of NTPase events. Less attention has been given to how
individual subunits within the hexamer contribute to substrate
binding and translocation. For example, it is not clear whether
globally cooperative ATPase activity must invariably be coupled
to globally cooperative substrate handling. A key unresolved
issue is whether a single ring-translocase can exploit different
modes of intersubunit collaboration to remodel substrates that
impose disparate mechanical demands.
Here, we elucidate that Hsp104 subunits collaborate via radi-
cally different mechanisms to disaggregate disordered aggre-
gates versus amyloid. Unexpectedly, the E. coli homolog of
Hsp104, ClpB, coordinates subunit collaboration differently
thanHsp104, even thoughHsp104 andClpB arewidely assumed
to function by the same mechanism (Doyle and Wickner, 2009).
Hsp104 exhibits operational plasticity that confers adaptable
disaggregase activity suited for the demands of the yeast pro-
teome, which include prion disaggregation. In contrast, ClpB is
finely tuned for optimal disordered aggregate dissolution and
has limited ability to dissolve amyloid.
RESULTS
Experimental Logic
We employed a mutant doping strategy to determine the
contribution of individual subunits toward protein disaggregationand thereby define mechanochemical coupling mechanisms
of Hsp104 hexamers. Thus, mutant subunits defective in ATP
hydrolysis or substrate binding are mixed with wild-type (WT)
subunits to generate heterohexamer ensembles according to
a binomial distribution that is determined by the WT:mutant
ratio (Figure 1A). This strategy has yielded key insights for other
NTP-fueled ring-translocases but is dependent upon random
mixing of mutant andWT subunits at the monomer level (Moreau
et al., 2007; Werbeck et al., 2008).
First, we employed several techniques to verify statistical WT
and mutant Hsp104 (Hsp104DPL, Hsp104DWA, Hsp104DWB, or
Hsp104DWBDPL) subunit mixing and heterohexamer ensemble
formation. These techniques included (1) affinity chromatog-
raphy to separate heterohexamers with different numbers of bio-
tinylated subunits (Figures S1A–S1D available online) or different
numbers of his-tagged subunits (Figures S1E–S1I); (2) kinetic
sensitivity of Hsp104-catalyzed green fluorescent protein (GFP)
disaggregation to excess mutant subunit (Figure S1J); and (3)
fluorescence energy transfer between labeled subunits to detect
subunit mixing within Hsp104 hexamers (Figures S2A–S2J).
Thus, we establish that (1) Hsp104 forms dynamic hexamers
that rapidly exchange subunits on the minute timescale (Fig-
ures S1A–S1J and S2A–S2J) similar to ClpB (Werbeck et al.,
2008) and (2) specific mutant subunits (Hsp104DPL, Hsp104DWA,
Hsp104DWB, or Hsp104DWBDPL) defective in substrate binding or
ATP hydrolysis (or both) incorporate statistically into WT hexam-
ers just as well as WT subunits (Figures S1A–S1J and S2A–S2J).
Thus, Hsp104 provides a highly tractable system for mutant
doping studies.
Importantly, this rapid and statistical subunit exchange
allows generation of heterohexamer ensembles comprised of
WT and mutant subunits according to a binomial distribution
that varies as a function of the molar ratio of each subunit
(Figures 1A and S1D–S1I; see Extended Experimental Proce-
dures) (Werbeck et al., 2008). Using this distribution, we can
predict how disaggregase activity would be inhibited at various
mutant:WT ratios if a specified number of mutant subunits
inactivate the hexamer (Figure 1B; see Extended Experimental
Procedures). Thus, if all six subunits must work together, then
one mutant subunit would abolish hexamer activity (Figure 1B,
dark blue curve). If the activity of a single subunit within
the hexamer is sufficient, then some activity would still be
observed with five mutant subunits per hexamer, and only six
mutant subunits would abolish activity (Figure 1B, orange
line). By comparing experimental data with theoretical plots,
we can determine whether subunit collaboration within Hsp104
hexamers is probabilistic (six mutant subunits abolish activity),
subglobally cooperative (two to five mutant subunits abolish
activity), or globally cooperative (one mutant subunit abolishes
activity).
Hsp104 Uses a Probabilistic Mechanism to Dissolve
Disordered Aggregates
To define how Hsp104 subunits coordinate substrate binding,
we employed Hsp104DPL, which harbors Y257A and Y662A
mutations in the NBD1 and NBD2 channel loops that impair
substrate binding (Lum et al., 2008). Importantly, Hsp104DPL
has WT ATPase activity (Figure 1C), incorporates into WTCell 151, 778–793, November 9, 2012 ª2012 Elsevier Inc. 779
Figure 1. Hsp104 Uses a Probabilistic Mechanism to Dissolve Disordered Aggregates
(A) Theoretical Hsp104 hexamer ensembles containing zero (black), one (blue), two (green), three (orange), four (red), five (purple), and sixmutant subunits (yellow)
as a function of the fraction of mutant subunit present.
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hexamers just as well as WT Hsp104 (Figures S1D–S1F and
S2J), and hasminimal effect on total ATPase activity whenmixed
with WT Hsp104 (Figure 1D, gray markers).
We assembled heterohexamer ensembles of WT Hsp104 and
Hsp104DPL and assessed disaggregase activity against disor-
dered luciferase aggregates. Dilution of Hsp104 with buffer
had little effect, whereas addition of Hsp104DPL caused a roughly
linear decline in disaggregase activity (Figures 1E and 1F).
Similar data were obtainedwith heat-denatured GFP aggregates
and heat-denatured citrate synthase (CS) aggregates (Figures
S3A and S3B). This tolerance of Hsp104 hexamers to Hsp104DPL
subunits suggests that, for disordered aggregates, Hsp104
translocates substrate in a probabilistic manner. Thus, a single
WT subunit per hexamer can catalyze disaggregation.
This probabilistic mechanism of substrate handling is con-
served over 2 billion years of evolution to E. coli ClpB. ClpB dis-
played a roughly linear decline in luciferase disaggregation
activity in response to a substrate-binding-defective variant,
ClpBDPL (Y251A:Y653A) (Weibezahn et al., 2004), whereas buffer
had no effect (Figures 1E and 1F).
This noncooperative substrate handling was surprising
because Hsp104 cooperatively hydrolyzes ATP (Hattendorf
and Lindquist, 2002). To determine the role of individual subunits
with respect to ATP hydrolysis, we utilized ATPase-defective
Hsp104DWA, which harbors K218T and K620T mutations in the
NBD1 and NBD2 Walker A motifs. These mutations severely
inhibit ATP hydrolysis (Figure 1C) by reducing affinity for ATP
but do not impair hexamerization at the Hsp104 concentrations
employed here (Schirmer et al., 2001). Indeed, Hsp104DWA incor-
porated into WT hexamers just like WT Hsp104 (Figures S1C–
S1E, S1G, and S2J). Doping revealed that Hsp104DWA subunits
inhibited total ATPase activity slightly less than predicted by
a linear response (Figure 1D, compare purple markers to orange
line). Strikingly, Hsp104DWA subunits elicited a roughly linear
decline in luciferase, GFP, and CS disaggregation by Hsp104
(Figures 1G, S3C, and S3D). Thus, Hsp104 couples probabilistic
ATPase activity and substrate handling to disordered aggregate
dissolution, indicating that the Hsp104 power stroke can be
generated by ATP hydrolysis in a single subunit.(B) Theoretical activity curves where one or more (blue), two or more (red), three
subunits (orange) are needed to ablate hexamer activity.
(C) WT or mutant Hsp104 ATPase activity. Values represent means ±SEM (n = 3
(D) Hsp104 wasmixed with increasing fractions of mutant Hsp104 proteins or buff
Orange line indicates expected ATPase activity if six mutant subunits are neede
(E–I) Luciferase aggregateswere treatedwith Hsp104 (graymarkers), Hsc70 (anH
Hsp104DWA (G), Hsp104DWB (H), or Hsp104DPLDWB (I). Alternatively, luciferase ag
increasing fractions of buffer (E), ClpBDPL (F), ClpBDWA (G), ClpBDWB (H), or ClpB
represent means ±SEM (n = 3–4). Theoretical disaggregase activity if six (orange l
line [H and I]) ablate hexamer activity. Pink line (I) indicates simulated activity if a
adjacent to a mutant subunit.
(J and K) WT yeast carrying the indicated Hsp104 plasmid or Dhsp104 yeast ha
spotted (J). The spotting on the right is a 5-fold dilution of the spotting on the le
represent means ±SEM (n = 3).
(L)WT orDhsp104 yeast expressing luciferase and the indicated Hsp104 variant w
Luciferase activity (% of the WT+vector control) was determined. Values represe
(M) Adjacent pairs of WT-WT or WT mutant subunits determine hexamer activity,
has an activity of 1/6. By contrast, adjacentWTmutant pairs have a stimulated act
experimental luciferase disaggregation data obtained with Hsp104DPLDWB.
See also Figures S1, S2, and S3.ClpB Hexamers Are Tuned Differently to Hsp104
Hexamers
These findings were surprising because mutant doping with
ClpB indicated that highly cooperative ATP hydrolysis powers
disordered aggregate dissolution (Hoskins et al., 2009). Indeed,
ATPase-defective ClpBDWA (K212T:K611T) caused a sharp
nonlinear decline in ClpB disaggregase activity, which is con-
sistent with two mutant subunits abolishing hexamer activity
(Figures 1B and 1G). We also assessed ClpBDWB, which bears
E279Q and E678Q mutations in the NBD1 and NBD2 Walker B
motifs. ClpBDWB forms hexamers that bind but do not hydrolyze
ATP (Weibezahn et al., 2003). Doping ClpBDWB elicited a sharp
nonlinear decline in disaggregase activity such that one to two
mutant subunits abolish hexamer activity (Figures 1B and 1H).
Thus, unlike Hsp104, ClpB subunits couple highly collaborative
ATPase activity to probabilistic substrate handling to dissolve
disordered aggregates.
ClpBDWB is a substrate ‘‘trap’’ (Weibezahn et al., 2003), which
might poison WT hexamers by not releasing substrate rather
than by perturbing intersubunit coordination of ATP hydrolysis.
To address this issue, we constructed ClpBDPLDWB in which the
substrate-binding pore loops and Walker B motifs are mutated
(Y251A:E279Q:Y653A:E678Q). Doping ClpBDPLDWB caused a
sharp decline in luciferase reactivation such that one to two
mutant subunits ablated activity (Figure 1I). Thus, substrate
binding by ClpBDWB does not poison WT hexamers. Rather,
five to six ClpB subunits per hexamer must hydrolyze ATP for
protein disaggregation. Surprisingly, this highly coordinated
ATPase pattern of ClpB hexamers is coupled to stochastic
substrate binding (Figures 1F–1H).
Hsp104 Hexamers Tolerate Multiple Subunits Defective
in ATP Hydrolysis and Substrate Binding
Weobtained dissimilar results with Hsp104. Hsp104DWB (E285Q:
E687Q) and Hsp104DPLDWB (Y257A:E285Q:Y662A:E687Q) have
little ATPase activity and incorporate into WT hexamers as pre-
dicted (Figures 1C, S1D, S1E, S1H, S1I, S2J). Like Hsp104DWA,
Hsp104DWB subunits caused a roughly linear decline in total
ATPase activity (Figure 1D, compare red markers to orangeor more (green), four or more (purple), five or more (light blue), or six mutant
–5).
er, and ATPase activity was assessed. Values represent means ±SEM (n = 3–5).
d to ablate hexamer activity.
sp70), andHdj2 (anHsp40) plus increasing fractions of buffer (E), Hsp104DPL (F),
gregates were treated with ClpB (blue markers), DnaK, DnaJ, and GrpE plus
DPLDWB (I). Luciferase reactivation (% WT activity) was then assessed. Values
ine [F and G]), two or more (red line [G–I]), or one or more mutant subunits (blue
mutant subunit stimulates an adjacent WT subunit 1.4-fold but is inhibitory if
rboring an emptor vector control were treated at 50C for 0–20 min and then
ft. Alternatively, cells were plated and survival (%) was calculated (K). Values
ere shifted to 44C, treatedwith cycloheximide, and allowed to recover at 30C.
nt means ±SEM (n = 3).
whereas adjacent mutant subunits have no activity. Each adjacent WT-WT pair
ivity (s), and the effect of various values of s is depicted. Brownmarkers indicate
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line). In contrast, Hsp104DPLDWB had little effect on total ATPase
activity unless the fraction of mutant subunit exceeded 50%, in
which case inhibition was similar to Hsp104DWB (Figure 1D,
compare green to red markers). Similar to ClpB, one to two
Hsp104DWB subunits per hexamer abolished disaggregase
activity (Figures 1H, S3E, and S3F). Unlike ClpB, inhibition was
partially rescued by the substrate-binding loop mutations in
Hsp104DPLDWB (Figures 1I, S3G, and S3H). Thus, it is not the
ATPase defect but ‘‘substrate trapping’’ by a single Hsp104DWB
subunit that poisons a hexamer with five WT subunits. Indeed,
Hsp104DWA confers a similar ATPase defect to Hsp104DWB (Fig-
ure 1D) but cannot interact with substrate (Bo¨sl et al., 2005) and
does not elicit a sharp decline in disaggregase activity (Figures
1G and 1H). Consistent with these in vitro findings, Hsp104DWB
has a more severe dominant-negative effect than Hsp104DPL
or Hsp104DPLDWB on Hsp104 function in thermotolerance and
luciferase disaggregation in vivo (Figures 1J–1L).
The response to Hsp104DPLDWB subunits was unusual. Rather
than a linear decline, we observed little effect at low fractions
of Hsp104DPLDWB and a sharp decline when the fraction of
Hsp104DPLDWB subunit exceeded 66.7% (Figure 1I). We could
model this behavior if we imposed rules whereby a mutant
subunit stimulates the activity of an adjacent WT subunit by
1.4-fold but exerts an inhibitory effect if it is adjacent to
a mutant subunit (Figures 1I, S3G, and S3H, compare pink line
to gray markers; see Extended Experimental Procedures and
Figure 1M). Thus, Hsp104 hexamers operate via principles
distinct from those of ClpB hexamers. The Hsp104 hexamer dis-
plays greater plasticity. It tolerates a wider variety of subunit-in-
activating events without gross perturbations in disaggregase
activity. For example, an Hsp104 subunit that (1) binds but
cannot hydrolyze ATP and (2) is unable to engage substrate
can stimulate the disaggregase activity of an adjacent subunit.
In ClpB, a single subunit with these properties inactivates the
entire hexamer.
Hsp104 Remodels Diverse Amyloids, Whereas ClpB Has
Limited Activity
Hsp104 plasticity might ensure inheritance of numerous benefi-
cial prions (Alberti et al., 2009). By contrast, although E. coli
exploits functional amyloid on the cell surface, it is not known
to harbor cytoplasmic prions and barely supports Sup35 prion
formation (Barnhart and Chapman, 2006; Garrity et al., 2010).
Indeed, ClpB has limited ability to remodel Sup35 prions (Reidy
et al., 2012; Shorter and Lindquist, 2004). However, it is unknown
whether this limitation extends to other amyloids.
We tested whether Hsp104 and ClpB disaggregated various
amyloids formed by proteins with diverse primary sequences,
including yeast prion proteins Sup35, Ure2, and Rnq1. WeFigure 2. Hsp104 Disaggregates Diverse Amyloids, Whereas ClpB Doe
(A–D) Sup35, Ure2, Rnq1 or Ab42, tau, K18, a-synWT, a-synA53T, a-synA30P, a-sy
nation of Hsp104, Ssa1, Sis1, or Hsp104DWA (A and B) or ClpB, DnaK, DnaJ, and
sedimentation (B and D). Values represent means ±SEM (n = 3).
(E) Sup35, Ure2, Ab42, tau, a-synWT, and Q62 amyloids were treated with tClpB o
means ±SEM (n = 3).
(F) ATPase activity of ClpB or Hsp104 in the presence of the indicated aggregate
See also Figure S4 and Table S1.also tested whether Hsp104 and ClpB disaggregated various
amyloids formed by proteins linked to Alzheimer disease, PD,
HD, or type 2 diabetes, such as Ab42, tau (and K18, a tau
fragment), a-syn (WT and PD-linked variants: A53T, A30P,
and E46K), polyglutamine (Q62 and Q81), and amylin (Cush-
man et al., 2010). Hsp104DWA was inactive, but Hsp104 remod-
eled the majority of these amyloids in a manner that was
slightly enhanced by Hsp70 (Ssa1) and Hsp40 (Sis1), which
were inactive alone (Figures 2A and 2B). Rnq1 prions were
an exception that necessitated Hsp70 and Hsp40, whereas
a-synE46K, Ab42, and Q81 amyloids were generally more
refractory (Figures 2A and 2B). Thus, Hsp70 and Hsp40 are
not always essential for Hsp104 to disaggregate diverse
cross-b structures. We suggest that a generic feature of
amyloid unleashes Hsp104 disaggregase activity in the
absence of Hsp70 and Hsp40.
ClpB had limited ability to disaggregate amyloid with or
without Hsp70 (DnaK) and Hsp40 (DnaJ) (Figures 2C and 2D).
Indeed, we varied ClpB, DnaK, DnaJ, and GrpE concentration
(0–50 mM), incubation time (0–96 hr), and ATP concentration
(0–25 mM) but could not establish conditions in which ClpB
disaggregated amyloid. Similarly, ClpB from T. thermophilus
was unable to disaggregate amyloid, whereas the A. thaliana
homolog, Hsp101, remodeled various amyloids (Figure 2E).
The lowClpB activity might reflect a lack of unknown cofactors
that enable amyloid disaggregation. However, E. coli cytosol had
limited ability to disaggregate amyloid and did not stimulate ClpB
(Figure S4A). In contrast, yeast cytosol remodeled diverse
amyloids, whereasDhsp104 yeast cytosol did not unless supple-
mented with Hsp104 (Figure S4B). Thus, the failure of E. coli
cytosol to stimulate amyloid disaggregation by ClpB indicated
that cofactors were not missing and that ClpB has limited
amyloid-disaggregase activity.
The inability of ClpB to disaggregate amyloid (Figures 2C and
2D) might reflect a reduced binding affinity for amyloid. Yet, the
Kd of ClpB and Hsp104 for each amyloid and disordered aggre-
gate used here was similar and ranged from 30–100 nM (Table
S1). Thus, some aspect of amyloid antagonizes ClpB, but not
Hsp104, after initial engagement.
ClpB is more sensitive than Hsp104 to ATPase-defective
subunits (Figures 1G and 1I). Thus, amyloid might inhibit the
ATPase activity of sufficient ClpB subunits per hexamer to ablate
activity. Indeed, amyloids inhibited ClpB ATPase activity by
30%, whereas disordered aggregates stimulated by 20%
(Figure 2F). Hsp104 ATPase activity was stimulated by disor-
dered aggregates and several amyloids, but some amyloids
had no effect (Figure 2F). Thus, amyloid specifically inhibits
ClpB ATPase activity, which might explain ClpB’s limited
amyloid-disaggregase activity.s Not
nE46K, Q62, Q81, and amylin amyloids were treated with the indicated combi-
GrpE (C and D). Fiber integrity was assessed by ThT fluorescence (A and C) or
r Hsp101. Fiber integrity was assessed by ThT fluorescence. Values represent
d substrate. Values represent means ±SEM (n = 3).
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Figure 3. ClpB Reactivates Disordered Aggregates More Effectively Than Hsp104
(A) Luciferase aggregateswere treatedwith the indicated combination of E. coliWTcytosol,E. coliDclpb cytosol, ClpB, yeastWT cytosol, yeastDhsp104 cytosol,
or Hsp104. Luciferase reactivation was assessed (% of total recoverable activity). Values represent means ±SEM (n = 3).
(B–D) Disordered luciferase aggregates (B), disordered GFP aggregates (C), or disordered CS aggregates (D) were treated with ClpB, DnaK, DnaJ, and GrpE or
Hsp104, Ssa1, and Sis1. Reactivation was then assessed (% of total recoverable activity). Values represent means ±SEM (n = 3).
See also Table S1.ClpB Reactivates Disordered Aggregates More
Effectively Than Hsp104
E. coli cytosol was more active than yeast cytosol in reactivating
aggregated luciferase, whereas Dclpb E. coli cytosol was inac-
tive but could be rescued by pure ClpB (Figure 3A). Accordingly,
ClpB was more effective than Hsp104 in disordered aggregate
dissolution (Figures 3B–3D). Thus, ClpB appears more adapted
to resolve disordered aggregates that accrue upon protein-
folding stress but is ineffective against amyloid.
Hsp104 Uses a Distinct Mechanism to Resolve Toxic
Oligomers and Amyloids
Next, we analyzed Hsp104-catalyzed disassembly of toxic prea-
myloid oligomers and amyloid formedby thePD-linkeda-synA30P
and Ure2 prions. Disassembly of a-synA30P oligomers, a-synA30P
amyloid, and Ure2 prions by Hsp104 was very sensitive to
Hsp104DPL (Figures 4A–4C), Hsp104DWA (Figures 4D–4F), and
Hsp104DPLDWB (Figures 4G–4I). Hsp104’s ability to disassemble784 Cell 151, 778–793, November 9, 2012 ª2012 Elsevier Inc.a-SynA30P oligomers was abolished by approximately two
mutant subunits per hexamer (Figures 4A, 4D, and 4G), whereas
a-SynA30P amyloid and Ure2 prion disassembly were ablated by
onemutant subunit per hexamer (Figures 4B, 4C, 4E, 4F, 4H, and
4I). Thus, more subunits must work together to disaggregate
amyloid compared to disordered aggregates. These data sug-
gest that Hsp104 hexamers switch to a highly cooperative
mode of ATP hydrolysis and substrate handling to disassemble
preamyloid oligomers and amyloids.
The response to mutant subunits (Hsp104DPL, Hsp104DWA,
and Hsp104DPLDWB) was invariant for amyloid remodeling,
whereas the same mutant subunits elicit diverse responses in
disordered aggregate dissolution (e.g., compare Figures 4B,
4E, and 4H to Figures 1F, 1G, and 1I). Thus, amyloids make
more stringent demands on how Hsp104 subunits must collabo-
rate to promote disaggregation.
Missing cofactors might enable Hsp104 to disaggregate
amyloid by using a probabilistic mechanism as for disordered
Figure 4. Hsp104 Exploits Cooperative Mechanisms to Remodel Preamyloid a-synA30P Oligomers, a-synA30P Amyloids, and Ure2 Prions
(A–I) a-synA30P oligomers (A, D, and G), a-synA30P amyloid (B, E, and H), or Ure2 prions (C, F, and I) were treated with Hsp104, Ssa1, and Sis1 plus increasing
fractions of buffer (A, B, and C), Hsp104DPL (A, B, and C), Hsp104DWA (D, E, and F), or Hsp104DPLDWB (G, H, and I). Oligomer remodeling was assessed by filter
trap, and amyloid remodeling was assessed by ThT fluorescence (gray or blackmarkers) or sedimentation (purple or yellowmarkers). Activity was converted to%
WT activity. Values represent means ±SEM (n = 2–4). Expected activity if one ormore (blue line [A–I]) or two ormore (red line [A–I]) mutant subunits ablate hexamer
activity.
See also Figure S4.aggregates. For example, Hsp26 can assist Hsp104 in protein
disaggregation (Duennwald et al., 2012). However, neither
Hsp26 nor Dhsp104 yeast cytosol (to provide the entire cohort
of molecular chaperones) altered the response of Hsp104 to
Hsp104DPL subunits in luciferase or Ure2 prion disaggregation
(Figures S4C and S4D). Thus, missing cofactors are unlikely to
alter the mechanism by which Hsp104 subunits collaborate to
disaggregate disordered aggregates versus amyloid.
Hsp104 Switches Mechanism to Disaggregate Distinct
Sup35 Prion Strains
Amyloidogenic proteins form structurally distinct amyloid
‘‘strains,’’ which can vary in stability and confer distinct pheno-types (Cushman et al., 2010). Hsp104 subunits might collabo-
rate differently to disaggregate distinct amyloid strains formed
by the same protein. To examine this possibility, we exploited
Sup35’s prion domain, termed NM, which spontaneously forms
different prion strains at different temperatures. NM prions
formed at 4C, termed NM4, possess a shorter, less stable
amyloid core (Tm 54C) with distinctive intermolecular
contacts and give rise to ‘‘strong’’ [PSI+] variants in vivo
(Krishnan and Lindquist, 2005) (Figure S5). Here, strength refers
to the nonsense suppression phenotype caused by prion-medi-
ated depletion of soluble Sup35 (Shorter and Lindquist, 2005).
NM prions formed at 25 or 37C, termed NM25 and NM37,
harbor longer, more stable amyloid cores (Tm 81C forCell 151, 778–793, November 9, 2012 ª2012 Elsevier Inc. 785
Figure 5. Hsp104 Switches Mechanism to Remodel Distinct Sup35 Prion Strains
(A–I) NM4, NM25, or NM37 prions were treated with Hsp104, Ssa1, and Sis1 plus increasing fractions of buffer (A, D, and G), Hsp104DPL (A, D, and G), Hsp104DWA
(B, E, and H), or Hsp104DPLDWB (C, F, and I). Remodeling wasmonitored by ThT fluorescence (gray or black markers) or sedimentation (purple or yellowmarkers).
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NM25 and Tm 86C for NM37) with intermolecular contacts
distinct from NM4 and give rise to ‘‘weak’’ [PSI+] variants in vivo
(Krishnan and Lindquist, 2005) (Figure S5). NM4, NM25, and
NM37 provide an opportunity to assess Hsp104 activity against
alternative prion structures formed by the same primary
sequence.
Remodeling each NM prion strain required a different mode
of intersubunit collaboration by Hsp104. Thus, NM4 remodel-
ing was less sensitive than NM25 or NM37 to Hsp104DPL
(Figures 5A, 5D, and 5G), Hsp104DWA (Figures 5B, 5E, and 5H),
Hsp104DPLDWB (Figures 5C, 5F, and 5I), or Hsp104DWB (data
not shown). NM4 remodeling was ablated by approximately
three to four mutant subunits per hexamer, whereas NM25 re-
modeling was ablated by one mutant subunit per hexamer (see
Figure 1B). NM37 remodeling was unusually sensitive to mutant
subunits (Figures 5G–5I), suggesting that more than one hex-
amer is needed to remodel this strain. Thus, as the length of
the cross-b core of the NM prion increases and encroaches
further into C-terminal sequence (Figure S5), the mechanism
by which Hsp104 subunits collaborate switches to become
more cooperative. For NM4, a subglobal cooperative mecha-
nism will suffice, whereas NM25 requires global cooperativity.
Next, we tested the efficacy by which mutant Hsp104 sub-
units disrupt propagation of different [PSI+] variants by Hsp104
in vivo (Chernoff et al., 1995). In accord with our in vitro data,
Hsp104DPL, Hsp104DWA, Hsp104DWB, and Hsp104DPLDWB more
readily disrupted propagation of weak [PSI+] encoded by NM37
or NM25 than propagation of strong [PSI+] encoded byNM4 (Fig-
ure 5J). Thus, Hsp104-driven remodeling of weak [PSI+] prions
(NM25 and NM37) is more sensitive to Hsp104DPL, Hsp104DWA,
Hsp104DWB, and Hsp104DPLDWB subunits than Hsp104-driven
remodeling of strong [PSI+] prions (NM4) in vitro and in vivo
(Figures 5A–5J). Importantly, theseHsp104 variants were equally
effective in disrupting the Hsp104-catalyzed remodeling of a
given [PSI+] variant in vitro and in vivo (Figures 5A–5J). Unlike their
effects on thermotolerance or in vivo luciferase reactivation,
Hsp104DWB was not a more effective dominant negative than
Hsp104DPL or Hsp104DPLDWB (Figures 1J–1L and 5J). Thus, the
mechanismbywhichHsp104 remodels prions versus disordered
aggregates differs in vivo.
Hsp104 Switches Mechanism to Disaggregate
Disordered Aggregates versus Prions
We confirmed that Hsp104 switches mechanism to resolve
disordered aggregates versus prions by using two strategies
that do not employ mutant subunits. First, we used p370, a short
peptide that competitively inhibits Hsp104-substrate binding
(Lum et al., 2008). Importantly, Hsp104-catalyzed luciferase re-
activation was insensitive to a 20-fold excess of p370, whereas
NM4 remodeling was inhibited and NM37 remodeling was abol-
ished (Figure 6A). A negative control peptide, pSGG, had no
effect (Figure 6A). Thus, in accord with Hsp104DPL doping (Fig-
ures 1F, 5B, and 5H), amyloid disaggregation by Hsp104 isActivity was converted to % WT activity. Values represent means ±SEM (n = 2–4
[A–C]), or one or more (blue line [D–I]) mutant subunits ablate hexamer activity.
(J) Strong and weak [PSI+] curing by Hsp104DPL, Hsp104DWA, Hsp104DPLDWB, or
See also Figure S5.more sensitive to inhibition of substrate binding than disordered
aggregate dissolution.
Next, we examined the effect of various ratios of ATP and
ATPgS, a slowly hydrolyzable ATP analog. We kept the total
nucleotide concentration constant but varied the ATP:ATPgS
ratio from 12:0 to 0:12. Luciferase reactivation by Hsp104,
Hsp70, and Hsp40 was largely unaffected by increasing frac-
tions of ATPgS. Optimal activity was observed at 7:5 or 6:6
ATP:ATPgS, and a ratio of 4:8 ATP:ATPgS supported activity
similar to reactions with just ATP (Figure 6B). Activity was even
detected at 1:11 ATP:ATPgS (Figure 6B). Hsp104 alone was
inactive with ATP, but addition of ATPgS unleashed activity,
and a 6:6 ATP:ATPgS ratio elicited maximal Hsp104 activity
(Figure 6B). These activity profiles illustrate the adaptability of
the Hsp104 hexamer, which can effectively disaggregate lucif-
erase when diverse ATP:ATPgS mixtures populate its NBDs.
In contrast, Hsp104-catalyzed remodeling of NM4 was sharply
inhibited by low fractions of ATPgS, and NM37 was even more
sensitive (Figures 6C and 6D). Thus, WT Hsp104 uses a dis-
tinct mechanism to disaggregate disordered aggregates versus
amyloid.
Key Middle Domain and NBD2 Residues Enable Hsp104
to Switch Mechanism
Wehypothesized that Hsp104 variants that are functional in ther-
motolerance but defective in prion propagation in vivo might be
unable to switch mechanism. We focused on Hsp104D704N and
Hsp104L462R, which confer WT thermotolerance but cannot
propagate [PSI+], [RNQ+], or [URE3] (Kurahashi and Nakamura,
2007). D704 is between the NBD2Walker B and sensor-1 motifs,
whereas L462 is in helix 2 of the middle domain. D704 is pre-
dicted to contact the middle domain, whereas L462 is predicted
to be in proximity to nucleotide in NBD1 (Wendler et al., 2007).
Thus, D704 and L462 could mediate the interdomain or intersu-
bunit communication necessary to switch mechanism.
In vitro, Hsp104D704N had reduced ATPase activity, whereas
Hsp104L462R had WT levels of ATPase activity (Figure 6E).
Both mutants had reduced ability to reactivate luciferase
aggregates and could not remodel NM25 (Figure 6E), which
explains their ability to confer thermotolerance, but not prion
propagation, in vivo (Kurahashi and Nakamura, 2007). Very little
functional Hsp104 is required for thermotolerance (Lindquist
and Kim, 1996). Thus, reduced Hsp104D704N or Hsp104L462R
activity against disordered aggregates is likely sufficient for
thermotolerance, especially when cells are given a conditioning
pretreatment.
The limited ability of Hsp104D704N andHsp104L462R to remodel
amyloid is reminiscent of ClpB (Figures 2C and 2D). Thus,
Hsp104D704N and Hsp104L462R subunits might also collaborate
differently than WT Hsp104 subunits to dissolve disordered
aggregates. To probe how Hsp104D704N and Hsp104L462R
subunits collaborate in luciferase reactivation, we doped in
mutant Hsp104D704N and Hsp104L462R subunits defective in). Expected activity if four or more (purple line [A–C]), three or more (green line
Hsp104DWB overexpression. Values represent means ±SEM (n = 3).
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Figure 6. Selective Ablation of Amyloid Disaggregase Activity by p370, ATPgS, Hsp104D704N, or Hsp104L462R Subunits
(A) Luciferase aggregates, NM4 prions, or NM37 prions were treated with Hsp104, Ssa1, and Sis1 plus buffer, p370, or pSGG. Disaggregase activity was
converted to % activity in the absence of peptide. Values represent means ±SEM (n = 2).
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ATP hydrolysis (DWA) or ATP hydrolysis and substrate binding
(DPLDWB). For Hsp104D704N, activity declined sharply upon
doping Hsp104D704NDWA, which is consistent with two to three
mutant subunits inactivating the Hsp104D704N hexamer (Fig-
ure 6F). Thus, Hsp104D704N exploits a subglobally cooperative
mechanism of ATP hydrolysis to reactivate luciferase, unlike
WT Hsp104, which uses a probabilistic mechanism (Figure 1G).
Indeed, Hsp104D704N responds to ATPase-defective subunits
more like ClpB (Figure 1G), which has limited amyloid-remodel-
ing activity (Figures 2C and 2D). Hsp104D704NDPLDWB subunits
elicited an approximately linear decline in Hsp104D704N lucif-
erase reactivation activity (Figure 6F) rather than the stimulation
observed with WT Hsp104 or sharp inhibition observed with
ClpB (Figure 1I). Unlike WT Hsp104, Hsp104D704N subunits with
defective ATPase and substrate-binding activity do not stimulate
adjacent Hsp104D704N subunits. Thus, D704N impairs intersubu-
nit communication and precludes amyloid disaggregation.
Hsp104L462R subunits collaborated differently than
Hsp104D704N and WT Hsp104 subunits to disaggregate lucif-
erase. DopingHsp104L462RDWA caused a roughly linear decline in
Hsp104L462R activity, indicating a probabilistic mechanism akin
to WT Hsp104 (Figures 1G and 6G). Doping Hsp104L462RDPLDWB
elicited a roughly linear decline in Hsp104L462R luciferase re-
activation activity rather than the stimulation observed with
WT Hsp104 (Figures 1I and 6G). Thus, Hsp104L462R subunits
with defective ATPase and substrate-binding activity do not
stimulate adjacent Hsp104L462R subunits. We conclude that
L462R disrupts intersubunit communication and ablates amyloid
remodeling.
Doping Hsp104D704N or Hsp104L462R subunits had little
effect on luciferase reactivation by WT Hsp104, even though
Hsp104D704N and Hsp104L462R are 5–9-fold less active than
WT Hsp104 against luciferase (Figures 6E and 6H). These data
reillustrate the resilience of the Hsp104 hexamer and its capacity
to accommodate defective subunits and still effectively resolve
disordered aggregates. Even an average of one WT subunit
per Hsp104D704N or Hsp104L462R hexamer is capable of cata-
lyzing the same amount of disaggregation as a WT hexamer
(Figure 6H). By contrast, Hsp104D704N or Hsp104L462R subunits
caused a sharp decline in Hsp104-catalyzed NM25 remodeling
consistent with one mutant subunit disrupting hexamer activity(B) Luciferase aggregateswere treatedwith Hsp104, Hsc70, and Hdj2 or Hsp104 a
activity of Hsp104, Hsc70, and Hdj2 plus ATP. Values represent means ±SEM (n
(C andD) NM4 prions (C) or NM37 prions (D) were treatedwith Hsp104, Ssa1, and S
converted to % activity of Hsp104, Ssa1, and Sis1 plus ATP. Values represent m
(E) Comparison of ATPase activity, luciferase reactivation activity, and NM25 dis
activity was converted to % WT activity. Values represent means ±SEM (n = 2–3
(F) Luciferase aggregates were treated with Hsp104D704N, Hsc70, and Hdj2 plus
(blue markers). Luciferase reactivation was converted to % Hsp104D704N activity.
(red line) mutant subunits ablate hexamer activity. Values represent means ±SEM
(G) Luciferase aggregates were treated with Hsp104L462R, Hsc70, and Hdj2 plus
(blue markers). Luciferase reactivation was converted to % Hsp104L462R activity
ablate hexamer activity. Values represent means ±SEM (n = 3).
(H) Luciferase aggregates were treated with Hsp104, Hsc70, and Hdj2 plus increa
Luciferase reactivation was converted to % WT Hsp104 activity. Orange line ind
activity. Values represent means ±SEM (n = 2).
(I) NM25 was treated with Hsp104, Ssa1, and Sis1 plus increasing fractions of H
Activitywas converted to%WTHsp104 activity. Predicted activity (blue bars) if one(Figure 6I). Thus, D704 and L462 likely transmit or receive signals
that recruit additional Hsp104 subunits for amyloid disaggrega-
tion. Impairing intersubunit communication with specific muta-
tions, such as D704N or L462R, yields Hsp104 variants that
dissolve disordered aggregates, but not amyloid.
DISCUSSION
We have established that Hsp104 employs distinct modes of in-
tersubunit collaboration to resolve disordered aggregates versus
amyloid. For disordered aggregates, Hsp104 subunits use
probabilistic ATP hydrolysis similar to the mechanism defined
for ClpX, a protein unfoldase (Martin et al., 2005). However,
unlike ClpX, Hsp104 withstands subunits that cannot bind
substrate. ClpX hexamers are severely impaired by two subunits
that cannot engage substrate (Martin et al., 2008), whereas
Hsp104 retains 70% activity. This sensitivity might explain
why ClpX is a poor protein disaggregase (Doyle et al., 2007a).
The permissive nature of Hsp104 hexamers to subunits that
cannot hydrolyze ATP or engage substrate enables a highly
flexible disaggregase. Thus, one WT subunit per hexamer is
sufficient to catalyze disaggregation (Figure 7A). Indeed, any
opportunely positioned subunit within the hexamer that can
hydrolyze ATP and engage the irregular and heterogeneous
aggregated structure can promote disaggregation. Individual
subunits do not have to coordinate ATPase or substrate-binding
events with neighboring subunits or wait until all subunits are
engaged, which may be sterically improbable. Thus, Hsp104
can resolve the unrelated proteins of the aggregated proteome
after stress.
Surprisingly, ClpB, the E. coli homolog of Hsp104, is tuned
differently to Hsp104. Like Hsp104, ClpB exploits probabilistic
substrate binding to dissolve disordered aggregates and toler-
ates subunits that cannot bind substrate (Figure 7B). This shared
feature of ClpB and Hsp104 distinguishes them from the protein
unfoldase, ClpX.
Unlike Hsp104, ClpB couples probabilistic substrate binding
to highly cooperative ATP hydrolysis (Figure 7B). Unexpectedly,
this operating mode enables ClpB to dissolve disordered
aggregates more effectively than Hsp104. However, this
enhancement comes at the expense of robust disaggregaselone plus various ATP:ATPgS ratios. Disaggregase activity was converted to%
= 3).
is1 or Hsp104 alone plus various ATP:ATPgS ratios. Disaggregase activity was
eans ±SEM (n = 3).
aggregase activity of WT Hsp104, Hsp104D704N, and Hsp104L462R. Observed
).
increasing fractions of Hsp104D704NDWA (gray markers) or Hsp104D704NDPLDWB
Expected activity if six (orange line), three or more (green line), or two or more
(n = 3).
increasing fractions of Hsp104L462RDWA (gray markers) or Hsp104L462RDPLDWB
. Orange line indicates expected activity if six mutant subunits are needed to
sing fractions of Hsp104D704N (purple markers) or Hsp104L462R (greenmarkers).
icates expected activity if six mutant subunits are needed to ablate hexamer
sp104D704N or Hsp104L462R. Remodeling was monitored by ThT fluorescence.
mutant subunit ablates hexamer activity. Values representmeans±SEM (n = 2).
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Figure 7. Mechanisms of Intersubunit Collaboration for Hsp104 and ClpB
(A–D) Hsp104 (A, C, and D) or ClpB (B) subunits are depicted as spheres, and a single aggregated conformer is displayed. Green subunits are engaged in
productive disaggregation via substrate binding (depicted by a lever) and/or ATP hydrolysis. Yellow subunits have completed their role in disaggregation. Blue
subunits are resting and do not need to hydrolyze ATP or engage substrate for successful disaggregation. Red subunits recruit resting subunits until a sufficient
number are recruited to promote disaggregation.
(A) Hsp104 couples probabilistic ATPase activity and substrate binding to resolve disordered aggregates. Thus, a single subunit within a hexamer that can bind
substrate and hydrolyze ATP is sufficient to drive protein disaggregation.
(B) ClpB exploits cooperative ATPase activity and probabilistic substrate binding to resolve disordered aggregates. Five or six ClpB subunits per hexamer must
hydrolyze ATP to disaggregate disordered aggregates. Cooperative ATPase activity is not coupled to cooperative substrate handling, as one ClpB subunit
capable of binding substrate can drive disaggregation provided five or six subunits can hydrolyze ATP.
(C) Hsp104 switches to a subglobal cooperative mechanism of ATP hydrolysis and substrate binding to resolve NM4 prions. One subunit initially engages
amyloid, but the localized structural stability of the cross-b form antagonizes unfolding, which elicits a signal (red subunit) that recruits additional subunits until
a sufficient number are recruited that can together unfold the cross-b structure. For NM4, three subunits per hexamer must engage substrate and hydrolyze ATP.
(D) Hsp104 switches to a global cooperative mechanism of ATP hydrolysis and substrate binding to resolve more refractory amyloids, such as NM25 prions.
Hsp104 subunits collaborate as in (C) except that the local stability of the amyloid fold is even more antagonistic, such that six subunits must be recruited to
engage substrate and hydrolyze ATP for disaggregation.activity able to accommodate ATPase-defective subunits. Unlike
Hsp104, ClpB hexamers cannot tolerate a single ATPase-defec-
tive subunit. Our data also suggest that, unlike Hsp104, ClpB has
limited ability to couple cooperative ATPase activity to coopera-
tive substrate handling, which is necessary to remodel amyloid.
The robustness and plasticity of Hsp104 hexamers are likely
an adaptation that enables amyloid remodeling and empowers
yeast to exploit prions for beneficial purposes. Indeed, ClpB
and E. coli cytosol were unable to remodel amyloid. Amyloid
can accumulate in E. coli upon protein overexpression (Wang
et al., 2008). Yet, ClpB’s limited amyloid-remodeling activity
suggests that E. coli compartmentalizes amyloid rather than
disseminating it throughout the cytoplasm. Yeast also parti-
tion amyloid, but simultaneously disperse cytosolic prions for790 Cell 151, 778–793, November 9, 2012 ª2012 Elsevier Inc.beneficial purposes. The profound selective advantages af-
forded by yeast prions are only made possible by Hsp104’s
potent amyloid-remodeling activity (Alberti et al., 2009; Half-
mann et al., 2012; Shorter and Lindquist, 2005).
We suggest that Hsp104’s default intersubunit collaboration
mechanism is probabilistic (Figure 7A). However, this default-
operating mode can be rapidly retuned to a suitable subglobal
or global cooperative mechanism upon sensing stable sub-
strates. Thus, amyloid likely antagonizes unfolding and elicits a
signal for Hsp104 subunits to work together to engage substrate,
hydrolyzeATP, andpromote disaggregation (Figures 7Cand 7D).
For less chemically stable NM4 prions, a subglobal cooperative
mechanism that is inactivated by three mutant subunits per hex-
amer is employed (Figure 7C). By contrast, NM25 prions, which
are more stable and possess a longer cross-b core, are resolved
by a global cooperative mechanism that is inactivated by one
mutant subunit (Figure 7D). Ure2 prions and a-synA30P amyloid
are also resolved in this way (Figure 7D). Cryo-EM reconstruc-
tions indicate that Hsp104 might use a cooperative, sequential
mechanism of substrate handling (Wendler et al., 2009). How-
ever, we suggest that hexamer plasticity enables Hsp104 to
adapt a variety of mechanochemical coupling mechanisms that
are responsive to the specific physical demands of the aggre-
gated substrate. Thus, Hsp104 is wired do the minimum work
necessary to disaggregate any given substrate, i.e., if two sub-
units are sufficient to rapidly disaggregate a substrate, then
only two will be used. Various multimeric, NTP-fueled ring-trans-
locaseswith diverse substrate portfolios could use similar adapt-
able repertoires of intersubunit collaboration.
We establish that D704N or L462R mutations impair inter-
subunit communication, reduce plasticity, and selectively ablate
amyloid disaggregation. Indeed, D704 and L462 likely transmit or
receive signals to recruit additional Hsp104 subunits during prion
disaggregation (Figures 7C and 7D). Although further studies
are needed to gain a structural understanding of how Hsp104
switches mechanism, our findings explain why Hsp104D704N
and Hsp104L462R are functional in thermotolerance but are
defective in prion propagation (Kurahashi and Nakamura, 2007).
Hsp104 might be designed to be more potent and selective
against specific proteins, which could empower facile puri-
fication of irksome recombinant proteins for basic or thera-
peutic purposes. Hsp104 could also be developed to target
select misfolded proteins in neurodegenerative disease (Vashist
et al., 2010). The intrinsic ability of Hsp104 to remodel diverse
disease-associated amyloids as well as toxic oligomers sug-
gests that this avenue warrants exploration. Here, it will be key
to increase the specificity of the Hsp104 hexamer for a target
polypeptidewhile simultaneously tuning plasticity such that toxic
conformers are selectively eradicated. For example, hypomor-
phic scaffolds based on Hsp104D704N or Hsp104L462R could be
useful in settings in which amyloids are protective and disor-
dered aggregates are toxic.
EXPERIMENTAL PROCEDURES
Modeling Heterohexamer Ensemble Activity
The bionomial distribution was used to simulate the activity of various hetero-







where P is the probability that a hexamer (therefore, n = 6) contains xmutant
subunits, and p is the probability that amutant subunit is incorporated. Subunit
mixing experiments demonstrated that mutant and WT subunits have a similar
probability of being incorporated into a hexamer (Figures S1D–S1I and S2J;
see Extended Experimental Procedures). Consequently, p is calculated as




Therefore, for any specified percentage of mutant subunits, the probability
distribution of Hsp104 hexamers containing zero, one, two, three, four, five,
or six mutant subunits can be derived (Figure 1A). Activity versus p plots (Fig-
ure 1B) could then be generated assuming each WT subunit makes an equalcontribution to the total activity (one-sixth per subunit). For more details, see
Extended Experimental Procedures.
Proteins
Proteins were purified by using standard protocols as described (Shorter and
Lindquist, 2004, 2006; Lo Bianco et al., 2008). For more details, see Extended
Experimental Procedures.
Cytosol Preparation
Yeast and bacterial cytosol were prepared as described except that cells were
lysed by using a French pressure cell (Glover and Lindquist, 1998) with modi-
fications as detailed in Extended Experimental Procedures.
ATPase Assay
Hsp104 (0.25 mM monomer) comprising the indicated fraction of WT Hsp104
and mutant was equilibrated in luciferase refolding buffer (LRB; 25 mM
HEPES-KOH [pH 7.4], 150 mM KAOc, 10 mM MgAOc, 10 mM DTT) for
15 min on ice and then incubated for 10 min at 25C in the presence of ATP
(1 mM). ATPase activity was assessed by the release of inorganic phosphate,
which was determined by using a malachite green phosphate detection kit
(Innova). For more details, see Extended Experimental Procedures.
Disaggregation Assays
Disaggregation of luciferase (50 nM), GFP (0.45 mM), CS (0.1 mM), various
amyloids (1–2.5 mM), and a-synA30P oligomers (1 mM) was performed in the
presence of Hsp104 or ClpB (0.167–20 mM) and the indicated Hsp70 (0.167–
6 mM) and Hsp40 (0.033–6 mM) plus ATP and ATP regeneration system as
described (Doyle et al., 2007b; Glover and Lindquist, 1998; Lo Bianco et al.,
2008; Shorter and Lindquist, 2004, 2006). For reactions containing ClpB,
GrpE (0.0167 mM) was also added. Total Hsp104 (or ClpB) was comprised of
either WT or mutant subunit or a 1:5, 2:4, 3:3, 4:2, and 5:1 mixture of the two
as indicated. WT and mutant mixtures were allowed to equilibrate for 15 min
on ice prior to addition to the reaction. For more details, see Extended Exper-
imental Procedures.
Thermotolerance, In Vivo Luciferase Reactivation, and [PSI+] Curing
Assays
In vivo thermotolerance, luciferase reactivation, and [PSI+] curing assays were
performed by using standard assays as described (Chernoff et al., 1995; Par-
sell et al., 1994: Wendler et al., 2007). Briefly, for thermotolerance, cells were
transferred to 50C for 0–20min and then spotted or plated on SGal-ura media
and grown at 30C to monitor survival. For luciferase reactivation, cells were
shifted to 44C for 60min and then allowed to recover in the presence of cyclo-
heximide (10 mg/ml) at 30C for 90 min, at which time luciferase activity was
determined. For [PSI+] curing, cells carrying the indicated plasmids weremain-
tained in midlog growth phase by dilution with SRafGal-ura media and plated
on 25% YPD. [PSI+] curing was then scored as the proportion of red ade
[psi] colonies. For more details, see Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.09.038.
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